Schedule 13G ownership disclosure

ADMA Biologics Inc

Common Stock · CUSIP: 000899104

Event date: 2024-12-31

Filing-level shares
11,296,255.00
Percent of class
4.8%
  • Invesco Ltd.

    Shares: 11,296,255.00 · Class: 4.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000914208-25-000062
Form type
SCHEDULE 13G/A
Filer
ADMA BIOLOGICS, INC.
CIK
CIK 1368514
Filed
Feb 07, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub